$IPCI Company News Intellipharmaceutics' Oxycodone

New Post Public Reply Private Reply Replies (0) Message Board

Sep 5, 2014 at 10:50 AM

$IPCI Company News

Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog 5:10 p.m. Aug. 29, 2014 - Zacks.com
IntelliPharmaCeutics (IPCI): Moving Average Crossover Alert - Tale of the Tape 11:14 a.m. July 29, 2014 - Zacks.com
Wall Street Is Overlooking Intellipharmaceutics- CFO Shameze Rampertab Tells Us Why 10:45 a.m. July 29, 2014 - Seeking Alpha
Why Intellipharmaceutics (IPCI) Stock Is Down Today 3:41 p.m. July 9, 2014 - TheStreet.com
IntelliPharmaCeutics International (IPCI) Crumbles: Stock Plunges by 13.3% - Tale of the Tape 8:30 a.m. July 9, 2014 - Zacks.com
Flamel Technologies SA (FLML) Soars: Stock Up 6.6% - Tale of the Tape 9:39 a.m. April 17, 2014 - Zacks.com
Tetraphase Slumps: TTPH Falls 10.3% in Session - Tale of the Tape 8:49 a.m. April 15, 2014 - Zacks.com
Flamel Technologies (FLML) Jumps: Stock Adds 9.8% in Session - Tale of the Tape 8:51 a.m. April 10, 2014 - Zacks.com
Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape 8:51 a.m. April 4, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Adds 5.4% in Session - Tale of the Tape 9:39 a.m. March 31, 2014 - Zacks.com
IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape 8:51 a.m. March 21, 2014 - Zacks.com
Can the Rally in IntelliPharmaCeutics (IPCI) Shares Continue? - Tale of the Tape 7:44 a.m. March 21, 2014 - Zacks.com
IntelliPharmaCeutics (IPCI) Jumps: Stock Up 8.9% - Tale of the Tape 8:51 a.m. March 11, 2014 - Zacks.com
Strong Demand For Resistance Technology Bodes Well For IntelliPharmaCeutics 1:06 p.m. Dec. 17, 2013 - Seeking Alpha
Thursday’s Biggest Stock Losers: SGOC, VJET, and More 5:56 a.m. Nov. 21, 2013 - InvestorPlace.com
Strength Seen in IntelliPharmaCeutics (IPCI): Stock Shoots 161.9% - Tale of the Tape 10:04 a.m. Nov. 20, 2013 - Zacks.com
Small Cap Stocks: Why IPCI Stock Went Bonkers 3:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Alcatel-Lucent Left in the Lurch by Nokia and 2 More Heavily Traded Stocks to Follow 5:14 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Intellipharmaceutics still Buy-rated following Focalin XR generic news 11:05 a.m. Nov. 19, 2013 - Seeking Alpha
Intellipharmaceutics nearly doubles on generic Focalin XR approval 9:31 a.m. Nov. 19, 2013 - Seeking Alpha

Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology 4:45 p.m. Aug. 28, 2014 - GlobeNewswire
Intellipharmaceutics Announces Second Quarter 2014 Results 6:01 p.m. July 7, 2014 - GlobeNewswire
Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement 5:46 p.m. May 20, 2014 - GlobeNewswire
Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma 8:09 a.m. May 8, 2014 - PR Newswire - PRF
Reviewing the Top Health Care Equities -- Research on IntelliPharmaCeutics, Delcath Systems, Valeant Pharma and Alkermes 5:39 p.m. March 21, 2014 - PR Newswire - PRF
Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014 5:00 p.m. March 19, 2014 - GlobeNewswire
Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwest, La Jolla Pharma, Merrimack Pharma, Rosetta, and IntelliPharmaCeutics 8:20 a.m. March 13, 2014 - PR Newswire - PRF
Intellipharmaceutics to Present at Two Upcoming Investor Conferences 6:00 p.m. March 4, 2014 - GlobeNewswire
Intellipharmaceutics Announces 2013 Year End Results 8:05 a.m. Feb. 18, 2014 - GlobeNewswire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 10:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc. 8:00 a.m. Feb. 3, 2014 - GlobeNewswire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 9:00 a.m. Dec. 2, 2013 - PR Newswire
Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference 8:00 a.m. Dec. 2, 2013 - GlobeNewswire
Intellipharmaceutics Announces At-The-Market Offering of Common Shares 5:30 p.m. Nov. 27, 2013 - GlobeNewswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 9:00 a.m. Nov. 22, 2013 - PR Newswire
TrendingWallStreet.com Releases Trend Research on NNRX, NWBO, FMCC, and IPCI 1:17 a.m. Nov. 21, 2013 - ACCESSWIRE
TrendingWallStreet.com Releases Volume Coverage on NCT, VEND, PGLO, and IPCI 1:20 a.m. Nov. 20, 2013 - ACCESSWIRE
HZNP, FB, GRPN and IPCI added to NASDAQ Active Stock Watch List at GSR 11:11 a.m. Nov. 19, 2013 - ACCESSWIRE
Intellipharmaceutics / Par to Make Immediate Commercial Launch of 15 and 30 mg Generic Focalin XR(R) 5:35 p.m. Nov. 18, 2013 - GlobeNewswire
Intellipharmaceutics Announces Third Quarter 2013 Results 5:00 p.m. Oct. 1, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UST Grabs Italdesign: Driving Future Mobility with AI

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

BYD's Chip Mastery Amid China's Auto Supply Tensions

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

NeuralTrust Expands to London as AI Risks Intensify

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

AION UT Sets New Safety Standard in Euro NCAP 2026

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Tech Breakthroughs in Cancer and Space Energy Aired

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Wooree Group Pushes for Rigorous Liposome Standards

Rallying for Rigorous Scientific Validation Ever find yourself pondering how many so-called 'innovative' health products really deliver what they promise? Let me tell ya, Wooree Group’s CEO, Ji-yong Yoon, ain’t buying into flimsy claims. At the Vitafoods Asia 2026 event in Bangkok, Yoon sent a clear message: Without scientific validation, calling a product 'liposomal'...

Coastal Property Realities: A Deep Dive into Ownership

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Insurance 101: Know Your Limits and Deductibles

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

$Aluminum Refractory Market to Hit $2.73B by 2031$

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

Nuix Leverages AI for Transformative Legal Review

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...